Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6026.0000 65.00 (1.09%)
NSE Aug 13, 2025 10:17 AM
Volume: 57,176
 

6026.00
1.09%
ICICI Securities Limited
The USFDA has communicated to Divi's Laboratories its intention to lift the import alert '99-32'' imposed on unit-II (that includes EOU, SEZ and DSN SEZ) of the Vizag API plant. USFDA had inspected this plant between November 29 and December 6, 2016 and issued a Form 483 to the unit with five observations. Subsequently, an import alert was issued to the products manufactured at unit-II under clauses 66-40 and 99-32, with an exemption for 12 products (10 products initially exempted and then two added later on), followed by a warning letter to the plant in May 2017....
Divi's Laboratories .. has an average target of 6447.40 from 5 brokers.
More from Divi's Laboratories Ltd.
Recommended